
Sunshield Chemicals (SUNSHIEL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.1B
Gross Profit
297.3M
26.11%
Operating Income
99.7M
8.75%
Net Income
68.2M
5.99%
EPS (Diluted)
₹9.28
Balance Sheet Metrics
Total Assets
3.0B
Total Liabilities
2.1B
Shareholders Equity
956.9M
Debt to Equity
2.18
Cash Flow Metrics
Revenue & Profitability Trend
Sunshield Chemicals Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 3.6B | 2.8B | 2.4B | 2.4B | 2.0B |
Cost of Goods Sold | 2.7B | 1.9B | 1.7B | 1.7B | 1.3B |
Gross Profit | 925.3M | 881.7M | 764.0M | 746.1M | 700.8M |
Gross Margin % | 25.3% | 31.3% | 31.3% | 30.6% | 35.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 110.8M | 89.0M | 94.9M | 64.3M | 66.3M |
Other Operating Expenses | 285.1M | 232.5M | 216.9M | 341.5M | 241.6M |
Total Operating Expenses | 395.9M | 321.6M | 311.8M | 405.8M | 307.9M |
Operating Income | 242.0M | 331.0M | 253.8M | 254.2M | 248.3M |
Operating Margin % | 6.6% | 11.7% | 10.4% | 10.4% | 12.5% |
Non-Operating Items | |||||
Interest Income | 1.3M | 2.6M | 672.0K | 1.1M | 178.0K |
Interest Expense | 82.4M | 72.6M | 68.4M | 47.8M | 70.2M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 180.5M | 267.4M | 190.8M | 391.8M | 166.2M |
Income Tax | 34.6M | 79.0M | 54.2M | 117.0M | 24.4M |
Effective Tax Rate % | 19.2% | 29.5% | 28.4% | 29.9% | 14.7% |
Net Income | 145.8M | 188.5M | 136.6M | 274.8M | 141.8M |
Net Margin % | 4.0% | 6.7% | 5.6% | 11.3% | 7.1% |
Key Metrics | |||||
EBITDA | 362.6M | 414.1M | 330.4M | 319.5M | 304.1M |
EPS (Basic) | ₹19.83 | ₹25.63 | ₹18.58 | ₹37.37 | ₹19.29 |
EPS (Diluted) | ₹19.83 | ₹25.63 | ₹18.58 | ₹37.37 | ₹19.29 |
Basic Shares Outstanding | 7353060 | 7353060 | 7353060 | 7353492 | 7353060 |
Diluted Shares Outstanding | 7353060 | 7353060 | 7353060 | 7353492 | 7353060 |
Income Statement Trend
Sunshield Chemicals Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 28.0M | 0 | 652.0K | 44.7M | 29.7M |
Short-term Investments | 9.6M | 6.2M | 17.2M | 13.7M | 6.0M |
Accounts Receivable | 640.9M | 478.9M | 401.1M | 413.4M | 286.8M |
Inventory | 570.1M | 432.8M | 363.7M | 294.0M | 260.9M |
Other Current Assets | 121.3M | 137.3M | 145.3M | 134.4M | 78.9M |
Total Current Assets | 1.4B | 1.1B | 928.3M | 900.6M | 663.2M |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.3B | 745.0M | 792.2M | 710.8M | 662.7M |
Goodwill | 1.7M | 1.9M | 1.9M | - | - |
Intangible Assets | 1.7M | 1.9M | 1.9M | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 33.5M | 32.7M | -2.0K | -1.0K | 1.0K |
Total Non-Current Assets | 1.7B | 1.2B | 843.9M | 834.3M | 717.8M |
Total Assets | 3.0B | 2.3B | 1.8B | 1.7B | 1.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 597.8M | 406.3M | 237.2M | 331.7M | 207.4M |
Short-term Debt | 808.5M | 693.7M | 360.7M | 435.4M | 378.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 255.1M | 11.7M | 8.1M | 8.0M | 7.5M |
Total Current Liabilities | 1.8B | 1.2B | 629.8M | 792.3M | 612.8M |
Non-Current Liabilities | |||||
Long-term Debt | 195.3M | 161.0M | 410.5M | 350.0M | 500.0M |
Deferred Tax Liabilities | 82.6M | 88.8M | 61.8M | 48.8M | 0 |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 307.5M | 268.1M | 482.4M | 405.9M | 506.7M |
Total Liabilities | 2.1B | 1.5B | 1.1B | 1.2B | 1.1B |
Equity | |||||
Common Stock | 73.5M | 73.5M | 73.5M | 73.5M | 73.5M |
Retained Earnings | 749.7M | 614.7M | 452.8M | 329.5M | 54.2M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 956.9M | 821.9M | 660.0M | 536.7M | 261.4M |
Key Metrics | |||||
Total Debt | 1.0B | 854.7M | 771.2M | 785.4M | 878.0M |
Working Capital | -409.6M | -146.0M | 298.5M | 108.3M | 50.4M |
Balance Sheet Composition
Sunshield Chemicals Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 180.5M | 267.4M | 190.8M | 391.8M | 166.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -45.8M | -127.3M | -67.1M | -208.1M | 74.5M |
Operating Cash Flow | 225.7M | 217.9M | 198.1M | 231.5M | 313.0M |
Investing Activities | |||||
Capital Expenditures | -498.4M | -414.5M | -81.8M | -163.4M | -30.8M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -3.2M | - | -3.5M | -7.7M | -6.0M |
Investment Sales | - | 11.2M | - | - | - |
Investing Cash Flow | -501.5M | -403.3M | -85.3M | -178.8M | -42.8M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -8.6M | -23.4M | -14.5M | - | - |
Debt Issuance | 229.0M | 50.0M | 437.6M | 1.2B | 150.0M |
Debt Repayment | -113.7M | -53.5M | -457.5M | -1.2B | -150.0M |
Financing Cash Flow | 106.7M | -26.9M | -34.4M | -34.6M | 0 |
Free Cash Flow | -18.5M | 6.2M | 59.0M | 166.3M | 307.5M |
Net Change in Cash | -169.1M | -212.3M | 78.4M | 18.0M | 270.2M |
Cash Flow Trend
Sunshield Chemicals Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
36.62
Price to Book
6.66
Price to Sales
1.59
PEG Ratio
0.52
Profitability Ratios
Profit Margin
4.33%
Operating Margin
8.76%
Return on Equity
15.24%
Return on Assets
4.79%
Financial Health
Current Ratio
0.77
Debt to Equity
104.90
Beta
0.54
Per Share Data
EPS (TTM)
₹23.67
Book Value per Share
₹130.13
Revenue per Share
₹546.48
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
sunshiel | 6.4B | 36.62 | 6.66 | 15.24% | 4.33% | 104.90 |
Asian Paints | 2.4T | 67.58 | 12.50 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.94 | 16.09 | 20.85% | 16.16% | 4.56 |
Tanfac Industries | 46.6B | 48.54 | 14.95 | 32.50% | 15.83% | 13.28 |
Kingfa Science | 46.2B | 30.12 | 6.35 | 20.98% | 8.58% | 5.90 |
Grauer & Weil | 42.1B | 26.73 | 4.48 | 16.73% | 13.35% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.